Northwestern Medicine scientists co-authored a study that identified a blood cell not normally found in the healthy brain that can invade brain tissue after status epilepticus, a type of seizure, and contributes to inflammation.
Northwestern Medicine scientists have received a $7.5 million grant to study how genetic information from African American patients can predict their responses to medications.
New Northwestern Medicine research has shown that reprogrammed stem cells can be used to identify patients with cancer who are likely to experience a dangerous side effect of a common chemotherapy drug.
In a new study, patients treated with one-fourth of the dose of beta-blockers tested in large clinical trials had a 20 to 25 percent increase in survival, indicating that dosing likely needs to be personalized for patients to get the best benefit.
A trail of messenger molecules left behind by general immune system cells called neutrophils helps virus-specific T-cells reach tissues infected by influenza, reports a new study published in Science.
Northwestern Medicine scientists received a five-year, $3.9 million grant from the National Institutes of Health to determine the optimal drug doses for treating pregnant women with depression.
Northwestern Medicine scientist Jeffrey Savas, PhD, and colleagues identified a receptor that sorts proteins in synapses, a finding that may augment future treatments for multiple neurological diseases and disorders.
Northwestern Medicine scientists investigated the mechanism behind a mutation in a calcium ion channel that leads to an immunodeficiency syndrome.
Northwestern Medicine scientists, inspired by treatments used by traditional healers in Nigeria, have synthesized four new chemical compounds that may lead to therapies for psychiatric disorders.
Male baldness clinical trials did not adequately report sexual dysfunction, which may persist long-term, according to a Northwestern Medicine meta-analysis of published reports of clinical trials of the drug finasteride.